US$ 23.03
glp 1 drug made by eli lilly Lilly's $1 Trillion Boom: Inside Dave Ricks' Weight-Loss Bet StockWatch: Investors Hammer Lilly as
Description
Medication delivered to your door

Indias growing diabetic population and increased healthcare infrastructure continue to drive the demand for diabetes treatments like GLP-1 receptor agonists

doi: 10.7326/0003-4819-138-1-200301070-00008

Cardiovascular Markers GLP-1 medications have demonstrated cardiovascular benefits in clinical trials

But it was soon realized that these drugs came with a bonus, since GLP-1 doesnt act only on the pancreas

Fifty-four percent of all patents listed on GLP-1 receptor agonists were on the delivery devices rather than active ingredients